AIM
IMGN

Assured Investment Management’s Immunogen Inc IMGN Stock Holding History

Assured Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-740
Closed -$2K – 942
2019
Q1 		$2K Sell
740
-54,518
-99% -$236K ﹤0.01% 1082
2018
Q4 		$265K Buy
55,258
+29,864
+118% +$181K 0.01% 826
2018
Q3 		$240K Sell
25,394
-1,171
-4% -$11.3K ﹤0.01% 941
2018
Q2 		$258K Sell
26,565
-6,753
-20% -$71.2K ﹤0.01% 956
2018
Q1 		$351K Buy
+33,318
New +$329K 0.01% 871

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assured Investment Management's IMGN Position: Q2 2019 in Review

Assured Investment Management sold out of Immunogen Inc (IMGN) in Q2 2019, closing a stake of 740 shares — an estimated $2K sold.

Assured Investment Management first reported a position in IMGN in Q1 2018 and held it in 5 quarters. The position peaked at $351K in Q1 2018. 192 funds tracked by Wall St. Rank hold IMGN as of Q2 2019.

  • Assured Investment Management reported no remaining Immunogen Inc position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 740 Immunogen Inc shares in Q2 2019, an estimated $2K.
  • Assured Investment Management first reported a position in Immunogen Inc in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Immunogen Inc position peaked at $351K in Q1 2018.
  • 192 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.